No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference39 articles.
1. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices - United States, July 2021;Rosenblum;MMWR Morb Mortal Wkly Rep,2021
2. Guillain-Barre syndrome as a cause of acute flaccid paralysis in Iraqi children: a result of 15 years of nation-wide study;Jasem;BMC Neurol,2013
3. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria;Fokke;Brain,2014
4. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009–2010;Greene;Am J Epidemiol,2012
5. Immunization safety review: influenza vaccines and neurological complications;Stratton,2004
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DARCVAA: A Deep Neural Networks Based Framework for Detecting Adverse Reactions of COVID-19 Vaccines and Association Analysis;SN Computer Science;2024-06-07
2. Guillain–Barré syndrome: immunopathogenesis and therapeutic targets;Expert Opinion on Therapeutic Targets;2024-03-03
3. Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Diplopia Caused by an Alternative Coronavirus Disease 2019 Vaccine;Case Reports in Neurological Medicine;2024-01
4. Guillain-Barré Syndrome;CONTINUUM: Lifelong Learning in Neurology;2023-10
5. Chronic inflammatory demyelinating polyneuropathy after SARS-CoV2 vaccination: update of the literature and patient characterization;Immunologic Research;2023-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3